Treadmill gait training with GaitBetter for Stroke

N/A

Waitlist Available

Led By Paolo Bonato, PhD

Research Sponsored by Spaulding Rehabilitation Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline scores at post-intervention (after 5 weeks)

Awards & highlights

No Placebo-Only Group

Summary

This trial tests the GaitBetter system, a tool to help stroke survivors improve their walking and thinking abilities. It focuses on people who have had a stroke and struggle with these functions. The system uses exercises to enhance both movement and mental skills.

Eligible Conditions

Stroke
Hemiplegia
Hemiplegic Shoulder Subluxation
Hemiplegic Gait

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline scores at post-intervention (after 5 weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline scores at post-intervention (after 5 weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline scores at post-intervention (after 5 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

10 meter walk test (in chronic stroke survivors, Aim 2)

10 meter walk test (in subacute stroke survivors, Aim 3)

Aim 3: Balance Evaluation Systems Test (mini-BESTest, in subacute stroke survivors, Aim 3)

+3 more

Secondary study objectives

Cerebrovascular accident

Stance time (in subacute stroke survivors, Aim 3)

Step length (in chronic stroke survivors, Aim 2)

+7 more

Other study objectives

12-Item Short Form Health Survey (SF-12) (in chronic stroke survivors, Aim 2)

Cerebrovascular accident

2-minutes walk test (2mwt) (in chronic stroke survivors, Aim 2)

+9 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Aim 3: Efficacy of the GaitBetter to improve rehabilitation outcomes in sub-acute stroke survivorsExperimental Treatment2 Interventions

The investigators propose a randomized, controlled study to evaluate the effects of using the GaitBetter system in patients with subacute stroke on recovery trajectory.

Group II: Aim 2: Efficacy of the GaitBetter to improve motor-cognitive function of chronic stroke survivorsExperimental Treatment1 Intervention

The investigators propose a single-arm, non-randomized study to test the hypothesis that the GaitBetter training is effective in improving gait and cognition in individuals with chronic stroke. This design was chosen given the expected stability of functional recovery in this population.

Do I qualify?Apply below to find out